Cited by 18Cardiac Health and Mental HealthCardiac pacing and defibrillation studiesCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators

Open access

Abstract

Background Implantable cardioverter-defibrillators (ICDs) are an effective treatment in some patients with inherited heart disease, including inherited channelopathies, yet they have also been shown to impact patients' psychological health. Objective We sought to improve understanding of the level of anxiety and depression as well as device acceptance among inherited channelopathy patients with an ICD. Methods Eligible patients seen at Johns Hopkins Hospital were sent a survey, which included the Hospital Anxiety and Depression Scale (HADS), Cardiac Anxiety Questionnaire (CAQ), and the Florida Patient Acceptance Survey (FPAS). Student t tests and χ 2 tests were used to identify associations with abnormal anxiety and depression scores. Results Among eligible patients (n = 65), 32 individuals (49%) completed the survey. The rate of device-related complications was 34%, and 41% of patients experienced 1 or more ICD shocks. Twelve patients (38%) had an abnormal HADS anxiety subscore and 5 patients (16%) had an abnormal HADS depression subscore (score ≥ 8). Secondary-prevention ICDs were associated with an abnormal HADS anxiety subscore ( P = .03). Experiencing ICD shock(s), device complications, age, sex, and family history of sudden cardiac death were not statistically associated with anxiety or depression. Overall, respondents demonstrated high device acceptance by FPAS (79.9 ± 2.9, maximum total score 100) and moderately high cardiac-specific anxiety by CAQ total score (1.53 ± 0.12). Conclusion A high prevalence of generalized anxiety was identified among inherited channelopathy patients with ICDs. High device acceptance and lack of association with ICD shocks or complications indicate that further research is necessary to understand this increased incidence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.hroo.2021.06.001

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Environmental modifiers such as endurance exercise, psychological stress, diet, alcohol, and metabolic dysregulation influence ACM disease penetrance and progression, in part through modulation of inflammatory processes.

    “environmental modifiers such as endurance exercise [24,25,26,27,28,29,30], psychological stress [31,32,33], diet [34,35], alcohol [36], and metabolic dysregulation [37,38,39] have been shown to influence disease penetrance and progression, in part, through modulation of inflammatory processes.”

    From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [33]

    The Discussion reports anxiety and depression in patients with inherited channelopathies and ICDs, but does not link psychological stress to ACM penetrance or progression. Searches for stress, inflammatory processes, and the other listed modifiers found no passage addressing the claimed mechanism. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 20

  1. Ingles, 2013, Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease, Int J Cardiol, 168, 3779, 10.1016/j.ijcard.2013.06.006 · DOI
  2. Olde Nordkamp, 2013, The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention, Circ Arrhythm Electrophysiol, 6, 91, 10.1161/CIRCEP.112.975268 · DOI
  3. Bostwick, 2011, An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life, Heart Fail Clin, 7, 101, 10.1016/j.hfc.2010.10.003 · DOI
  4. Ezzat, 2015, A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation?, Open Heart, 2, 10.1136/openhrt-2014-000198 · DOI
  5. Lee, 2010, Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database, J Am Coll Cardiol, 55, 774, 10.1016/j.jacc.2009.11.029 · DOI
  6. Jacq, 2009, A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients, Gen Hosp Psychiatry, 31, 266, 10.1016/j.genhosppsych.2009.01.003 · DOI
  7. Rhodes, 2017, Quality of life metrics in arrhythmogenic right ventricular cardiomyopathy patients: the impact of age, shock and sex, Int J Cardiol, 248, 216, 10.1016/j.ijcard.2017.08.026 · DOI
  8. James, 2012, General and disease-specific psychosocial adjustment in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy with implantable cardioverter defibrillators: a large cohort study, Circ Cardiovasc Genet, 5, 18, 10.1161/CIRCGENETICS.111.960898 · DOI · Paper page
  9. Ingles, 2008, Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy, Genet Med, 10, 117, 10.1097/GIM.0b013e3181612cc7 · DOI
  10. Bedair, 2015, Acceptance and psychological impact of implantable defibrillators amongst adults with congenital heart disease, Int J Cardiol, 181, 218, 10.1016/j.ijcard.2014.12.028 · DOI
  11. Al-Khatib, 2018, 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, Circulation, 138, e272
  12. Bjelland, 2002, The validity of the Hospital Anxiety and Depression Scale. An updated literature review, J Psychosom Res, 52, 69, 10.1016/S0022-3999(01)00296-3 · DOI · Paper page
  13. Burns, 2005, Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey, J Cardiovasc Electrophysiol, 16, 384, 10.1046/j.1540-8167.2005.40134.x · DOI
  14. Pimple, 2019, Psychological distress and subsequent cardiovascular events in individuals with coronary artery disease, J Am Heart Assoc, 8, 10.1161/JAHA.118.011866 · DOI
  15. O’Donovan, 2020, How patient perceptions shape responses and outcomes in inherited cardiac conditions, Heart Lung Circ, 29, 641, 10.1016/j.hlc.2019.11.003 · DOI
  16. Bilge, 2006, Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors, Pacing Clin Electrophysiol, 29, 619, 10.1111/j.1540-8159.2006.00409.x · DOI
  17. Hamang, 2011, General anxiety, depression, and physical health in relation to symptoms of heart-focused anxiety-a cross sectional study among patients living with the risk of serious arrhythmias and sudden cardiac death, Health Qual Life Outcomes, 9, 100, 10.1186/1477-7525-9-100 · DOI
  18. Richardson, 2018, Psychosocial implications of living with catecholaminergic polymorphic ventricular tachycardia in adulthood, J Genet Counsel, 27, 549, 10.1007/s10897-017-0152-1 · DOI
  19. Petersen, 2018, Implantable cardioverter-defibrillator therapy and device-related complications in young patients with inherited cardiomyopathies or channelopathies: a 17-year cohort study, Europace, 20, 1849, 10.1093/europace/euy081 · DOI
  20. van den Broek, 2009, Anxiety predicts poor perceived health in patients with an implantable defibrillator, Psychosomatics, 50, 483, 10.1016/S0033-3182(09)70841-2 · DOI

Cited by

Sorted by citations

Metadata

Authors
Singh, S. M., Murray, B., Tichnell, C., McClellan, R., James, C. A., & Barth, A. S.
Affiliations
Johns Hopkins University (US)
Corresponding author
Singh, Sajya M.
Venue
Heart Rhythm O2
Publisher
Elsevier BV
Published
2021-08
Volume
2
Issue
4
Pages
388-393
ISSN
2666-5018 (ISSN-L)
OpenAlex
W3170639904
Cited by
18
References
5
Citations by year
2026: 3 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 2
FWCI
2.01
Type
journal article
Language
en
Open access
Locations
  • Heart Rhythm O2 (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Boston Scientific Corporation
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
implantable cardioverter-defibrillator, inherited channelopathies, anxiety, depression, device acceptance, ICD shocks, device complications, secondary prevention, sudden cardiac death, mental health, cardiac anxiety

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review